A detailed history of Aqr Capital Management LLC transactions in Collegium Pharmaceutical, Inc stock. As of the latest transaction made, Aqr Capital Management LLC holds 129,010 shares of COLL stock, worth $3.76 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
129,010
Previous 101,956 26.53%
Holding current value
$3.76 Million
Previous $3.28 Million 51.86%
% of portfolio
0.01%
Previous 0.01%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$31.4 - $39.07 $849,495 - $1.06 Million
27,054 Added 26.53%
129,010 $4.98 Million
Q2 2024

Aug 14, 2024

SELL
$31.36 - $39.99 $224,851 - $286,728
-7,170 Reduced 6.57%
101,956 $3.28 Million
Q1 2024

May 15, 2024

BUY
$31.23 - $40.91 $123,670 - $162,003
3,960 Added 3.77%
109,126 $4.24 Million
Q4 2023

Feb 14, 2024

BUY
$21.16 - $30.8 $15,489 - $22,545
732 Added 0.7%
105,166 $3.24 Million
Q3 2023

Nov 14, 2023

BUY
$21.23 - $24.28 $1.17 Million - $1.34 Million
55,138 Added 111.85%
104,434 $2.33 Million
Q2 2023

Aug 14, 2023

BUY
$21.06 - $24.0 $714,186 - $813,888
33,912 Added 220.44%
49,296 $1.06 Million
Q1 2023

May 15, 2023

BUY
$23.0 - $29.88 $129,053 - $167,656
5,611 Added 57.41%
15,384 $369,000
Q4 2022

Feb 14, 2023

BUY
$16.14 - $23.55 $157,736 - $230,154
9,773 New
9,773 $226,000
Q2 2022

Aug 15, 2022

BUY
$14.22 - $20.88 $580,261 - $852,029
40,806 Added 118.55%
75,227 $1.33 Million
Q1 2022

May 16, 2022

BUY
$17.2 - $22.5 $348,558 - $455,962
20,265 Added 143.15%
34,421 $701,000
Q4 2021

Feb 14, 2022

BUY
$17.5 - $21.35 $17,640 - $21,520
1,008 Added 7.67%
14,156 $264,000
Q3 2021

Nov 15, 2021

SELL
$17.75 - $25.39 $8,307 - $11,882
-468 Reduced 3.44%
13,148 $260,000
Q2 2021

Aug 16, 2021

BUY
$21.74 - $25.28 $20,239 - $23,535
931 Added 7.34%
13,616 $322,000
Q1 2021

May 17, 2021

SELL
$19.25 - $26.1 $466,870 - $633,003
-24,253 Reduced 65.66%
12,685 $301,000
Q4 2020

Feb 16, 2021

SELL
$17.83 - $22.29 $348,576 - $435,769
-19,550 Reduced 34.61%
36,938 $740,000
Q3 2020

Nov 16, 2020

SELL
$15.78 - $20.82 $156,663 - $206,700
-9,928 Reduced 14.95%
56,488 $1.18 Million
Q2 2020

Aug 17, 2020

SELL
$15.49 - $23.51 $426,997 - $648,076
-27,566 Reduced 29.33%
66,416 $1.16 Million
Q1 2020

May 15, 2020

BUY
$13.89 - $25.45 $1.15 Million - $2.1 Million
82,485 Added 717.45%
93,982 $1.54 Million
Q4 2019

Feb 14, 2020

BUY
$10.7 - $22.24 $123,017 - $255,693
11,497 New
11,497 $237,000
Q3 2019

Nov 14, 2019

SELL
$10.16 - $13.28 $247,233 - $323,155
-24,334 Closed
0 $0
Q2 2019

Aug 14, 2019

BUY
$10.62 - $16.59 $258,427 - $403,701
24,334 New
24,334 $320,000
Q1 2019

May 14, 2019

SELL
$13.58 - $18.72 $235,409 - $324,511
-17,335 Closed
0 $0
Q4 2018

Feb 14, 2019

SELL
$14.78 - $19.68 $48,951 - $65,180
-3,312 Reduced 16.04%
17,335 $298,000
Q3 2018

Nov 15, 2018

SELL
$14.16 - $24.3 $54,501 - $93,530
-3,849 Reduced 15.71%
20,647 $304,000
Q2 2018

Aug 14, 2018

BUY
$21.79 - $28.29 $533,767 - $692,991
24,496 New
24,496 $584,000

Others Institutions Holding COLL

About COLLEGIUM PHARMACEUTICAL, INC


  • Ticker COLL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 34,126,200
  • Market Cap $995M
  • Description
  • Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...
More about COLL
Track This Portfolio

Track Aqr Capital Management LLC Portfolio

Follow Aqr Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aqr Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aqr Capital Management LLC with notifications on news.